Medline Inc. (MDLN)

Medline Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	1,159	1,200	234	-25
Depreciation & Amortization	1,011	977	951	933
Other Amortization	59	57	80	85
Loss (Gain) From Sale of Assets	-	-	-	6
Stock-Based Compensation	76	61	78	64
Provision & Write-off of Bad Debts	54	63	8	29
Other Operating Activities	168	86	135	14
Change in Accounts Receivable	-355	-256	-153	-376
Change in Inventory	-264	-545	444	-195
Change in Accounts Payable	73	106	136	-103
Change in Other Net Operating Assets	-237	20	-228	-245
Operating Cash Flow	1,744	1,769	1,685	187
Operating Cash Flow Growth	-1.41%	4.98%	801.07%	-
Capital Expenditures	-480	-364	-285	-254
Cash Acquisitions	6	-1,126	-16	-17
Investment in Securities	-	-	-	7
Other Investing Activities	-	-3	-11	-
Investing Cash Flow	-474	-1,493	-312	-264
Short-Term Debt Issued	179	166	-	80
Long-Term Debt Issued	7,569	15,932	-	-
Total Debt Issued	7,748	16,098	-	80
Short-Term Debt Repaid	-179	-166	-	-80
Long-Term Debt Repaid	-11,697	-15,995	-77	-61
Total Debt Repaid	-11,876	-16,161	-77	-141
Net Debt Issued (Repaid)	-4,128	-63	-77	-61
Issuance of Common Stock	7,048	-	-	-
Repurchase of Common Stock	-2,003	-20	-	-
Common Dividends Paid	-518	-1,518	-114	-23
Other Financing Activities	-	-12	-	-
Financing Cash Flow	399	-1,613	-191	-84
Foreign Exchange Rate Adjustments	23	2	4	-30
Net Cash Flow	1,692	-1,335	1,186	-191
Free Cash Flow	1,264	1,405	1,400	-67
Free Cash Flow Growth	-10.04%	0.36%	-	-
Free Cash Flow Margin	4.45%	5.51%	6.03%	-0.31%
Free Cash Flow Per Share	1.56	0.08	0.08	-
Cash Interest Paid	944	1,022	1,126	800
Cash Income Tax Paid	62	101	52	54
Levered Free Cash Flow	791.25	759.5	-	-
Unlevered Free Cash Flow	1,323	1,418	-	-
Change in Working Capital	-783	-675	199	-919

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q